Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Envveno Medical Corp (NVNO)
Envveno Medical Corp (NVNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 73,510
  • Shares Outstanding, K 13,317
  • Annual Sales, $ 0 K
  • Annual Income, $ -24,670 K
  • 60-Month Beta 1.06
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.68
Trade NVNO with:

Options Overview Details

View History
  • Implied Volatility 103.72% ( -0.73%)
  • Historical Volatility 81.80%
  • IV Percentile 73%
  • IV Rank 34.33%
  • IV High 278.39% on 10/30/23
  • IV Low 12.43% on 03/30/23
  • Put/Call Vol Ratio 0.07
  • Today's Volume 87
  • Volume Avg (30-Day) 109
  • Put/Call OI Ratio 0.03
  • Today's Open Interest 9,892
  • Open Int (30-Day) 12,339

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.00 +33.00%
on 01/22/24
5.95 -10.59%
on 02/20/24
+1.32 (+33.00%)
since 01/19/24
3-Month
3.40 +56.47%
on 11/30/23
5.95 -10.59%
on 02/20/24
+1.46 (+37.82%)
since 11/21/23
52-Week
2.51 +111.95%
on 06/07/23
5.95 -10.59%
on 02/20/24
-0.20 (-3.62%)
since 02/21/23

Most Recent Stories

More News
enVVeno Medical Posts Company Highlights and Materials from 2023 VEITH Symposium

- Interviews with patients from the VenoValve® pivotal study

NVNO : 5.32 (-3.62%)
enVVeno Medical Presents Positive Preliminary Device Related Material Adverse Event (MAE) Data from the VenoValve Pivotal Trial at the 50th Annual VEITH Symposium

IRVINE, CA / ACCESSWIRE / November 16, 2023 / enVVeno Medical Corporation (Nasdaq:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of venous disease, today...

NVNO : 5.32 (-3.62%)
enVVeno Medical Reports Third Quarter 2023 Financial Results and Provides Corporate Update

- $51.4 million cash on hand sufficient to fund current operations, including multiple value driving milestones, through the end of 2025

NVNO : 5.32 (-3.62%)
JTC Team Announces Presenting Company Line Up for the Virtual Investor “Ask the CEO” Conference Being Held October 24-25, 2023

- Live video webcast interactive Q&A with participating companies -

EVFM : 0.0270 (-15.63%)
GRI : 0.9600 (-1.03%)
MBRX : 0.5012 (+0.28%)
XBIO : 3.78 (-1.91%)
AREC : 1.3100 (-7.09%)
CNSP : 0.2863 (-1.28%)
NVNO : 5.32 (-3.62%)
PALI : 0.4290 (-2.50%)
enVVeno Medical to Participate at the Virtual Investor Ask the CEO Conference

Live moderated webcast with Robert Berman, Chief Executive Officer of enVVeno Medical on Wednesday, October 25th at 12:00 PM ET

NVNO : 5.32 (-3.62%)
enVVeno Medical Achieves Full Enrollment for VenoValve U.S. Pivotal Trial

- 18 VenoValve patients enrolled over the final two months of the study

NVNO : 5.32 (-3.62%)
enVVeno Medical Announces New Expedited Development Plan for the enVVe(R) Transcatheter Based Replacement Venous Valve

- enVVe development cycle to be reduced by 6 months

NVNO : 5.32 (-3.62%)
enVVeno Medical Announces Private Placement of $28 Million

Up to an additional $34 million of capital may become available from milestone-driven warrants in Q2, 2024 upon the release of initial topline efficacy data from the VenoValve pivotal trial

NVNO : 5.32 (-3.62%)
enVVeno Medical Announces the Issuance of a New Unique Category III CPT Code Covering the Insertion of a Bioprosthetic Valve into the Femoral Vein

IRVINE, CA / ACCESSWIRE / July 8, 2022 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of venous disease, today announced...

NVNO : 5.32 (-3.62%)
enVVeno Medical Reports First Quarter 2022 Financial Results and Provides Corporate Update

Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.

NVNO : 5.32 (-3.62%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

enVVeno Medical Corporation is a medical device company. It focuses in the treatment of venous disease. enVVeno Medical Corporation, formerly known as Hancock Jaffe Laboratories Inc., is based in IRVINE, CA.

See More

Key Turning Points

3rd Resistance Point 6.10
2nd Resistance Point 5.89
1st Resistance Point 5.61
Last Price 5.32
1st Support Level 5.12
2nd Support Level 4.91
3rd Support Level 4.63

See More

52-Week High 5.95
Last Price 5.32
Fibonacci 61.8% 4.64
Fibonacci 50% 4.23
Fibonacci 38.2% 3.82
52-Week Low 2.51

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar